Fig. 3. Comparison of prediction performance.

Slides:



Advertisements
Similar presentations
Colors.
Advertisements

Rank-order bar chart of percentage of patient-days with blood glucose results > 299 mg/dl for non-ICU units. Rank-order bar chart of percentage of patient-days.
Align The Stars Continue.
Align The Stars Continue.
Align The Stars Continue.
CsEN components reveal precisely timed cellular programs that characterize the dynamic changes of the peripheral immune system over the course of pregnancy.
Can I color yellow?. Can I color yellow?
Fig. 6. Effects of CD31-NP targeting in perfused human kidneys.
Fig. 4. Specific versus nonspecific NP accumulation.
What Color is it?.
Align The Stars Continue.
Examples of AEGIS autonomous target selection.
Fig. 3. H3N2 incidence forecasts based on the cluster model for the Unites States. H3N2 incidence forecasts based on the cluster model for the Unites States.
Analysis of Pentamer interfaces.
Fig. 4. Exemplars of two patterns of nosocomial MRSA spread.
Visual explanation of the interaction terms.
Visual explanation of the interaction terms.
Differential expression of TRM markers by donor- and recipient-derived T cells with time. Differential expression of TRM markers by donor- and recipient-derived.
Fig. 7 Correlation of NHP and human ISGs.
Fig. 1 Movement percepts for all participants.
Fig. 1. Distribution of TTNtv in healthy individuals and DCM patients, and TTN exon usage in the heart. Distribution of TTNtv in healthy individuals and.
Consolidated Standards of Reporting Trials flow diagram of VRC trial
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Filipin staining of marginal gyrus of cerebral cortex in NPC cats
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
Fig. 7 Bacterial dependency networks in IgA deficiency and HDs.
Source-based CP BCI robotic arm control.
Fig. 2 Quantification and mechanisms leading to the CAH for reentrant and doubly reentrant geometries at zero applied pressure. Quantification and mechanisms.
Fig. 1 Comparison of experimental and simulated NMR relaxation rates at 278 to 298 K. Comparison of experimental and simulated NMR relaxation rates at.
Fig. 5 Cell-free membrane cyclase assay confirms that candidate compounds are specific antagonists of hNPR1. Cell-free membrane cyclase assay confirms.
Optimization of a MYC degradation screen.
Fig. 2 LYM attractor metagene.
Fig. 2. Bacterial/viral score in COCONUT-conormalized whole-blood validation data sets. Bacterial/viral score in COCONUT-conormalized whole-blood validation.
Fig. 5. Vitamin B12 supplementation in the host altered the transcriptome of P. acnes in the skin microbiota. Vitamin B12 supplementation in the host altered.
Fig. 4 Visualization of the 20 occipital lobe models, trained to predict EmoNet categories from brain responses to emotional images. Visualization of the.
Fig. 1 Inbred mouse strains carrying monoclonal tumors display a symmetrical yet disparate response to ICB, associated with a distinctive gene signature.
Trends in the use of head CT and advanced imaging in patients treated with IV thrombolysis from 2008 to Trends in the use of head CT and advanced.
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
CsEN components reveal precisely timed cellular programs that characterize the dynamic changes of the peripheral immune system over the course of pregnancy.
Fig. 4. Long-term persistence of CTL019 cells and polyfunctionality in patients achieving CR. Long-term persistence of CTL019 cells and polyfunctionality.
Fig. 3 Forward model. Forward model. Summary of the resampled Monte Carlo simulations shown as histograms for epoch 1 (red), epoch 2 (green), and epoch.
Fig. 2 Activation of LRRK2 kinase in nigrostriatal dopamine neurons in human iPD postmortem brain tissue. Activation of LRRK2 kinase in nigrostriatal dopamine.
Fig. 3 Photon number statistics resulting from Fock state |l, S − l〉 interference. Photon number statistics resulting from Fock state |l, S − l〉 interference.
The microchip-based drug delivery device and overview of study design
Fig. 7. CIVO performance in canine lymphoma tumors demonstrates spatially restricted responses linked to drug mechanism. CIVO performance in canine lymphoma.
Fig. 1. A model to explain the pleiotropy of CEP290 disease.
Fig. 3 Transcriptional correlates of improved health in TRF
Fig. 4 Identification of C
Examples of AEGIS autonomous target selection.
Fig. 5 Active-state hallmarks of US28 bound to CX3CL1.
Fig. 6 Structural basis for the constitutive activity of US28.
Fig. 3 ET dynamics on the control and treatment watersheds during the pretreatment and treatment periods. ET dynamics on the control and treatment watersheds.
Fig. 2 PK dosing results. PK dosing results. (A) Plasma concentration of hPTH(1–34) versus time after release of 40-μg dose from implanted microchip device.
by Dezhi Kang, Baochen Shi, Marie C. Erfe, Noah Craft, and Huiying Li
Fig. 5. Vascularization of human liver seed grafts.
Fig. 2. Overexpression of miR cluster in the developing heart results in increased cardiomyocyte proliferation and cardiomegaly. Overexpression.
Delineating cancer evolution with single-cell sequencing
Fig. 4 Next-generation MOF with increased productivity.
Evolution-informed forecasting of seasonal influenza A (H3N2)‏
Fig. 5. High burdens of AA signature mutations and predicted immunogenicity in Taiwan HCCs. High burdens of AA signature mutations and predicted immunogenicity.
Fig. 2 Comparison of the observed DRs and the estimates by the VR model and FL. Comparison of the observed DRs and the estimates by the VR model and FL.
Fig. 8 DMN-Tre detects Mtb in sputum samples from patients with tuberculosis, similar to the auramine stain. DMN-Tre detects Mtb in sputum samples from.
Fig. 1 Subsequent memory paradigm and electrode coverage.
Fig. 2 Growth kinetics of borophene on silver.
Fig. 3. Association between peak CTL019 expansion and response.
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Fig. 2 Spatial distribution of five city groups.
Fig. 8 Immune correlates of protection.
Fig. 6. Connectivity and mobility maps for Lesotho.
Fig. 1. Maps of Lesotho, a landlocked country within South Africa.
Presentation transcript:

Fig. 3. Comparison of prediction performance. Comparison of prediction performance. (A) Each row represents a septic shock patient in the validation set from the time of ICU admission to the onset of septic shock. The graph was truncated to only show time points within 120 hours of septic shock onset. Individuals were aligned on the basis of time to septic shock after ICU admission. For visual clarity, we further subsorted individuals with similar time-to-shock by time of TREWScore identification. (B) Identification times for patients are shown from up to 48 hours before organ dysfunction until the onset of sepsis-related organ dysfunction (blue line). Patients were sorted by time to organ dysfunction and then for visual clarity, patients with similar times until the onset of organ dysfunction were subsorted by the time of identification by TREWScore. (C) Each row depicts a patient from the time of ICU admission (left edge) until the time of septic shock (red line). The individual’s data are shown in gray from the time of admission until first identification by either system. The bar then becomes orange if the patient was first identified by TREWScore or green if the patient was first identified by the routine screening protocol. This color continues unless the patient is later identified by the second system, at which point the bar becomes purple. If a patient is simultaneously identified by both systems, then the bar transitions directly from gray to purple. Katharine E. Henry et al., Sci Transl Med 2015;7:299ra122 Copyright © 2015, American Association for the Advancement of Science